These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 20201845)

  • 21. The importance of the adenosine A(2A) receptor-dopamine D(2) receptor interaction in drug addiction.
    Filip M; Zaniewska M; Frankowska M; Wydra K; Fuxe K
    Curr Med Chem; 2012; 19(3):317-55. PubMed ID: 22335511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior.
    Andreoli M; Tessari M; Pilla M; Valerio E; Hagan JJ; Heidbreder CA
    Neuropsychopharmacology; 2003 Jul; 28(7):1272-80. PubMed ID: 12700694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats.
    Song R; Bi GH; Zhang HY; Yang RF; Gardner EL; Li J; Xi ZX
    Neuropharmacology; 2014 Feb; 77():398-405. PubMed ID: 24176392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder.
    Barth V; Need AB; Tzavara ET; Giros B; Overshiner C; Gleason SD; Wade M; Johansson AM; Perry K; Nomikos GG; Witkin JM
    J Pharmacol Exp Ther; 2013 Feb; 344(2):501-10. PubMed ID: 23197772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats.
    Higley AE; Spiller K; Grundt P; Newman AH; Kiefer SW; Xi ZX; Gardner EL
    J Psychopharmacol; 2011 Feb; 25(2):263-73. PubMed ID: 20142301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat.
    Cervo L; Cocco A; Petrella C; Heidbreder CA
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):167-81. PubMed ID: 16426478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats.
    Galaj E; Ananthan S; Saliba M; Ranaldi R
    Psychopharmacology (Berl); 2014 Feb; 231(3):501-10. PubMed ID: 24037509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Dual-Target μ-Opioid Receptor and Dopamine D
    Bonifazi A; Battiti FO; Sanchez J; Zaidi SA; Bow E; Makarova M; Cao J; Shaik AB; Sulima A; Rice KC; Katritch V; Canals M; Lane JR; Newman AH
    J Med Chem; 2021 Jun; 64(11):7778-7808. PubMed ID: 34011153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.
    Rothman RB; Glowa JR
    Mol Neurobiol; 1995; 11(1-3):1-19. PubMed ID: 8561954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence.
    Murphy A; Nestor LJ; McGonigle J; Paterson L; Boyapati V; Ersche KD; Flechais R; Kuchibatla S; Metastasio A; Orban C; Passetti F; Reed L; Smith D; Suckling J; Taylor E; Robbins TW; Lingford-Hughes A; Nutt DJ; Deakin JF; Elliott R
    Neuropsychopharmacology; 2017 Apr; 42(5):1049-1057. PubMed ID: 28042871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia.
    Gross G; Wicke K; Drescher KU
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Feb; 386(2):155-66. PubMed ID: 23128852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.
    Peng XQ; Ashby CR; Spiller K; Li X; Li J; Thomasson N; Millan MJ; Mocaër E; Muńoz C; Gardner EL; Xi ZX
    Neuropharmacology; 2009 Mar; 56(4):752-60. PubMed ID: 19136017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats.
    Chen Y; Song R; Yang RF; Wu N; Li J
    Eur J Pharmacol; 2014 Nov; 743():126-32. PubMed ID: 25261038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dopamine D3 receptor and drug dependence: effects on reward or beyond?
    Le Foll B; Goldberg SR; Sokoloff P
    Neuropharmacology; 2005 Sep; 49(4):525-41. PubMed ID: 15963538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats.
    Xi ZX; Gilbert JG; Pak AC; Ashby CR; Heidbreder CA; Gardner EL
    Eur J Neurosci; 2005 Jun; 21(12):3427-38. PubMed ID: 16026480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D4 receptors in psychostimulant addiction.
    Di Ciano P; Grandy DK; Le Foll B
    Adv Pharmacol; 2014; 69():301-21. PubMed ID: 24484981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.
    Lv Y; Hu RR; Jing M; Zhao TY; Wu N; Song R; Li J; Hu G
    Acta Pharmacol Sin; 2019 May; 40(5):583-588. PubMed ID: 30224637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D1 and D3 receptor interactions in cocaine reward and seeking in rats.
    Galaj E; Harding W; Ranaldi R
    Psychopharmacology (Berl); 2016 Dec; 233(23-24):3881-3890. PubMed ID: 27582181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.